Risk factors for immunological sensitization to Mycobacterium tuberculosi s and progression to incident TB disease among HIV-uninfected adults in a high burden setting
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag100 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Humphrey Mulenga und 10 weiteren Autor:innen. Beteiligte Einrichtung: South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill & Melinda Gates Foundation, Strategic Health Innovation Partnerships, NIAID NIH HHS.
Abstract (Originalsprache)
Background
Identifying risk factors for Mtb sensitization (defined as IGRA-positive) and progression to TB disease is critical to guide targeted prevention strategies.
Methods
We analyzed data from a prospective cohort of adults (18–60 years) without HIV, enrolled at five high-incidence South African sites. Participants underwent testing for Mtb sensitization and microbiologically-confirmed TB at baseline, and during 15 months follow-up. Multivariable logistic and Cox regression models were used to assess factors associated with Mtb sensitization and TB progression. Sampling weights were applied to reflect the screened population.
Results
Among 2,912 participants with valid IGRA results, 63.4% (n=1895) were Mtb-sensitized. Prevalent TB was detected in 1.81% (62/1895) of Mtb-sensitized versus 0.62% (12/1017) of Mtb-unsensitized individuals (p=0.01). During follow-up of participants without prevalent TB, 2.01% (48/1833) Mtb-sensitized and 0.53% (8/1005) Mtb-unsensitized individuals developed TB (p=0.01). Factors associated with Mtb sensitization included increasing age (adjusted-odds-ratio; aOR=1.02 , 95%CI 1.01–1.03), male sex (aOR=1.34, 95%CI 1.08–1.67), smoking (aOR=1.31, 95%CI 1.05–1.64), prior TB (aOR=2.20, 95%CI 1.40–3.47), and TB contact history (aOR=1.40, 95%CI 1.08–1.83). Risk factors for progression to TB were Mtb sensitization (adjusted-hazard-ratio; aHR=3.05, 95%CI 1.14–8.18), smoking history (aHR=2.34, 95%CI 1.03–5.31), and lower body-mass index (aHR=0.89, 95%CI 0.82–0.97).
Conclusion
Mtb-sensitized individuals had a three-fold higher risk of prevalent TB and progressing to TB compared to Mtb-unsensitized individuals. In high-prevalence settings, identifying individuals at greatest risk—such as those recently infected, with a history of smoking, or low BMI—could help refine TB prevention efforts and reduce community-level transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
- Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, DST/NRF Centre of Excellence for Biomedical TB Research and SAMRC Centre for TB Research, Stellenbosch University, Cape…
- Centre for the AIDS Programme of Research in South Africa (CAPRISA)- SAMRC- HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZ…
- The Aurum Institute, Head office, Johannesburg, Gauteng, South Africa.
- School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Humphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland, Adam Penn-Nicholson, Munyaradzi Musvosvi, Michèle Tameris, Gerhard Walzl, Kogieleum Naidoo, Gavin Churchyard, Mark Hatherill
Förderung
- Bill & Melinda Gates Foundation
- Strategic Health Innovation Partnerships
- NIAID NIH HHS
- South African Department of Science and Technology
- Unit of the South African Medical Research Council
Zitieren
APA
Mulenga, H., Mendelsohn, S. C., Fiore-Gartland, A., Penn-Nicholson, A., Musvosvi, M., Tameris, M., Walzl, G., Naidoo, K., Churchyard, G., Scriba, T. J., & Hatherill, M. (2026). Risk factors for immunological sensitization to Mycobacterium tuberculosi s and progression to incident TB disease among HIV-uninfected adults in a high burden setting. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag100
Vancouver
Mulenga H, Mendelsohn SC, Fiore-Gartland A, Penn-Nicholson A, Musvosvi M, Tameris M, et al. Risk factors for immunological sensitization to Mycobacterium tuberculosi s and progression to incident TB disease among HIV-uninfected adults in a high burden setting. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag100
BibTeX
@article{Mulenga2026,
author = {Mulenga, Humphrey and Mendelsohn, Simon C and Fiore-Gartland, Andrew and Penn-Nicholson, Adam and Musvosvi, Munyaradzi and Tameris, Michèle and Walzl, Gerhard and Naidoo, Kogieleum and Churchyard, Gavin and Scriba, Thomas J and Hatherill, Mark},
title = {Risk factors for immunological sensitization to Mycobacterium tuberculosi s and progression to incident TB disease among HIV-uninfected adults in a high burden setting},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag100}
}
EUVIMED